Thermo Fisher Scientific Rift Valley Fever Virus Nucleocapsid Synthetic Peptide

Applications

Control (Ctrl)

• Assay-dependent

Blocking Assay (BLOCK)

• Assay-dependent

Product Specifications

Product Specific Information

This peptide corresponds to 17 amino acids near the center of Rift Valley Fever Virus.
For use as a blocking peptide in Western blot, incubate the peptide with equal volume of antibody for 30 min at 37ºC.

Target Information

Rift Valley Fever (RVF) virus is an arthropod-borne virus endemic to Africa that infects humans and animals, transmitted predominantly by mosquitoes.
During human infections, symptoms can range from mild fever to severe encephalitis and fatal hepatitis with hemorrhagic fever.
The Bunyaviridae family of viruses, to which the RVF virus belongs, are spherical enveloped viruses with a tripartite RNA genome of negative or ambisense polarity.
The three segments are referred to as the L, M, and S segments. The L and M segments are of negative polarity and code for the L-dependent RNA polymerase and glycoprotein precursor, respectively. The S segment is of ambisense polarity and encodes the nucleoprotein and non-structural proteins.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.